[Off-label use in oncology. Quackery or progress?].
Rebscher
Herbert
H
Vorstandsvorsitzender des Verbandes der Ersatzkrankenkassen e.V., Frankfurter Str. 84, D-53721 Siegburg.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000470:Alkaloids / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001600:Berberine Alkaloids; D018849:Controlled Clinical Trials as Topic; D004348:Drug Labeling; D004335:Drug and Narcotic Control; D006131:Growth Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007348:Insurance, Health; D009369:Neoplasms / Q000188:drug therapy*; D010617:Phenanthridines; D012106:Research
D000276:Adjuvants, Immunologic; D000470:Alkaloids; D000970:Antineoplastic Agents; D001600:Berberine Alkaloids; D006131:Growth Inhibitors; D010617:Phenanthridines; C060921:ukrain